Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a...
Q1 2026
May 12, 2026
FY 2025
Mar 12, 2026
Q4 2025
Q3 2025
Nov 13, 2025
Q2 2025
Aug 13, 2025